par Otmani, Khalid 
;Rouas, Redouane ;Berehab, Mimoune ;Lewalle, Philippe
Référence Biomedicine & pharmacotherapy, 171, 116165
Publication Publié, 2024-02
;Rouas, Redouane ;Berehab, Mimoune ;Lewalle, Philippe Référence Biomedicine & pharmacotherapy, 171, 116165
Publication Publié, 2024-02
Article révisé par les pairs
| Résumé : | Cancer development is a complex process that primarily results from the combination of genetic alterations and the dysregulation of major signalling pathways due to interference with the epigenetic machinery. As major epigenetic regulators, miRNAs are central players in the control of many key tumour development factors. These miRNAs have been classified as oncogenic miRNAs (oncomiRs) when they target tumour suppressor genes and tumour suppressor miRNAs (TS miRNAs) when they inhibit oncogene protein expression. Most of the mechanisms that modulate oncomiR expression are linked to transcriptional or posttranscriptional regulation. However, non-transcriptional processes, such as gene amplification, have been described as alternative processes that are responsible for increasing oncomiR expression. The current review summarises the different mechanisms controlling the upregulation of oncomiR expression in cancer cells and the tumour microenvironment (TME). Detailed knowledge of the mechanism underlying the regulation of oncomiR expression in cancer may pave the way for understanding the critical role of oncomiRs in cancer development and progression. |
